Schizophrenia database and biobank study
Part of Mental health clinical trials.
This study builds a database and collects samples (like blood) from people with schizophrenia to learn more about the condition. If you join, you help researchers understand schizophrenia better, which may lead to improved treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of schizophrenia based on the latest diagnostic criteria (ICD-11).
- Your diagnosis has been verified using a detailed interview called the SCID-5.
- You do not have other major mental health disorders like bipolar disorder or substance abuse (except alcohol or tobacco).
- You do not have a serious or sudden physical illness (like a heart attack or severe head injury).
- You do not have a known genetic condition like tuberous sclerosis or 22q11.2 deletion syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how immune system health relates to brain changes in people with schizophrenia. It uses brain imaging and electrical activity tests to understand these connections.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
This trial asks people who have schizophrenia to share their experience doing study activities, and it tests whether the study procedures work well for patients. It may help improve how future schizophrenia studies are run.
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
This study looks at how people with schizophrenia experience the process of joining and participating in clinical trials. It may help improve how future trials are explained and supported for patients.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.